Patent · US Active

Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives

US8734818B2 · kind B2 · utility

1Cited by
41References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 19, 2013
Grant dateMay 27, 2014
Priority date
Expiry dateFeb 19, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D209/88
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present specification discloses tetrahydroindolone derivatives or analogues and methods for treating cognitive/attention deficit disorders using such tetrahydroindolone derivatives and analogues.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.